Marshall Goldsmith

FEBRUARY 8, 2018

Co-founder of Rose Park Advisors—Disruptive Innovation Fund. A leading thinker on strategy and breakthrough innovation. Deepa Prahalad – Focused on design and emerging markets. Top-rated Clinical Professor of Management and Strategy, Northwestern Kellogg School of Management. Co-author: Predictable Magic.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Lead on Purpose

SEPTEMBER 8, 2009

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products. What was my strategy?

Committee 140

Committee Automotive Ethics Productivity 140

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

JULY 8, 2016

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Displacement generally is easier to combat than disruption. This presents Western companies with a fresh challenge.

Business Model 9

Business Model Innovation Company Apparel 9

Harvard Business Review

JUNE 7, 2012

The authors offer up five additional strategies in the full article. The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure. Looking for more?

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. Have you actually seen this done?”. The skepticism is warranted.

Innovation 9

Innovation P&L Short-term Company 9

Strategy Driven

MARCH 18, 2011

The Essential Advantage : How to Win with a Capabilities-Driven Strategy. The conventional wisdom about strategy may be leading your company astray. This book helps you identify your firm’s distinctive blend of strategic direction and differentiated capabilities that give you the ‘right to win’ in your chosen markets.

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

AUGUST 9, 2012

Selling pharmaceuticals in Latin America is not the same as selling them in the United States or Western Europe. Second, in most Latin American countries, pharmaceutical companies are not allowed to advertise directly to consumers. Right off the bat, I can identify four big differences. They were correct.

Pharmaceuticals 13

Pharmaceuticals Strategy Advertising Price 13

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 12

Innovation Company Biotechnology CFO 12

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JUNE 13, 2016

No matter how you look at it, there have been terrible, unintended outcomes from the introduction and marketing of next-generation prescription opioids. Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

JUNE 7, 2012

The authors offer up five additional strategies in the full article. The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure. Looking for more?

Disruptive Innovation 11

Disruptive Innovation Innovation Pharmaceuticals Class 11

Harvard Business Review

AUGUST 14, 2018

However, they have all failed in China, the world’s largest digital market. Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). market on China. market on China.

Competitive Advantage 9

Competitive Advantage Business Model Technology Marketing 9

Harvard Business Review

MARCH 18, 2018

Why the Pharmaceutical Industry Is Booming in Japan. Japan already enjoys the world’s second-biggest market in medical devices. percent of the 2014 global medical device market—behind the U.S. Philips, the Dutch electronics and health care corporation, is among the foreign companies attracted to Japan’s market.

Health Care 8

Health Care Industry Pharmaceuticals Content 8

Harvard Business Review

DECEMBER 5, 2016

Library leaders knew that given the immense changes brought on by digital innovations, as well as shifts in the communities that the Library served, it would need to evolve. Innovation communities had been used by Best Buy to grow its portion of the women’s consumer electronics market by $4.4b in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

JULY 4, 2017

With that in mind, I can see three potential scenarios for how Apple might play in the autonomous car market. Some of them may never enter the car market, or may at least significantly delay a move toward ownership. Apple has a great intuitive feel for how consumers see a market, versus how manufacturers see it. Or a kitchen?

Transportation 8

Transportation Sports Pharmaceuticals Health Care 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

OCTOBER 6, 2016

Barbara Kellerman from Harvard, Jeffrey Pfeffer from Stanford, and numerous other experts have pointed out that the development market is filled with fads — slick behavioral models and fun, engaging tools — that don’t really move the needle. The culture at GE, for example, centers on execution, simplicity, and innovation.

Leadership Pipeline 10

Leadership Pipeline Leadership After Action Review Pharmaceuticals 10

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. For them, openness is a better strategy.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

JULY 16, 2013

Consider the pharmaceutical industry, the focus of a recent global survey my colleagues and I conducted. A large pharmaceutical firm, for example, was about to make a big bet on a new class of drugs. But a panel of outside experts that had been assembled to critique the strategy warned management about an emerging risk.

Industry 8

Industry Pharmaceuticals Disruptive Innovation Strategic Planning 8

Harvard Business Review

JUNE 14, 2017

And ease of access means ease of market entry: Emerging data providers can get on their feet quickly and create new sources of competition. How the most innovative providers are creating value. But as more data and more data providers flood the market, a competitive position based solely on data becomes impossible to defend.

Health Care 8

Health Care Levitt Competitive Advantage Pharmaceuticals 8

Harvard Business Review

APRIL 16, 2012

Strategic cash provides more flexibility concerning the timing and pricing of potential acquisitions; having cash on hand is the best insurance that CFOs will be able to respond with alacrity to opportunities and not be subject to the vagaries of the financial markets. Facilitate Investments. Arguments Against Strategic Cash.

Company 13

Company Cost of Capital Finance Long-term 13

Harvard Business Review

DECEMBER 14, 2017

Is free-market magic finally bringing Amazon-style convenience, quality, and efficiency to health care? Some of the nation’s most innovative, high-performing non-profit health care organizations use this formula. This strategy could attract customers to both CVS and Aetna, add health care value, and even drive up profits.

Health Care 8

Health Care System Insurance Pharmaceuticals 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity.

Globalization 8

Globalization Supply Chain Pharmaceuticals McKinsey 8

Harvard Business Review

DECEMBER 18, 2014

This coalition has been able to consolidate the purchase of approximately $2 billion in medical devices, supplies, and pharmaceuticals each year, consistently saving 15% to 20% on contracted items year over year. Competitive strategy Healthcare' While collaboration is always challenging, the health care benefits are by now clear.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. For them, openness is a better strategy.

Supply Chain 8

Supply Chain Open-book Software Niche Marketing 8

Harvard Business Review

FEBRUARY 2, 2015

Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

SEPTEMBER 7, 2015

And the corporate executive playing games to improve his or her strategy-making skills is still rare. And second, the sophistication and effectiveness of strategy games at our disposal has risen tremendously. In the past two decades, strategy games have evolved from dull monochrome dialogs to well-designed AI-based apps.

Seminar 8

Seminar Learning Curve Strategy Comparison 8

Harvard Business Review

OCTOBER 13, 2011

Bank marketing materials focus on the dreams, anxieties and goals of consumers. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Financial institutions must find innovative ways to understand their consumers' aspirations and actual behavior.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

FEBRUARY 4, 2013

Just under 1,000 companies account for half of the world's market capitalization, Eccles notes. Our research with members of the global C-suite, and with leading sustainability and innovation experts, has identified seven vectors of breakthrough change. Perhaps surprisingly, two leading examples come from pharmaceutical companies.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

MAY 7, 2015

Strategies for staying ahead. Meanwhile, I had a lot friends and colleagues saying, “The capital markets are a huge problem.” My colleague Clayton Rose and I set out to discover whether the capital markets really are a problem, and we just couldn’t find much — or any — any evidence that this was true.

Short-term 8

Short-term Henderson Long-term Metrics 8

Harvard Business Review

OCTOBER 26, 2011

When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. By using these strategies, clean energy startups can better position themselves for acquisitions and promising exits.

Energy 10

Energy Finance IPO Biotechnology 10

Harvard Business Review

OCTOBER 24, 2017

These have forced AirBnB, Tesla, and Uber to make costly concessions to their operating practices or to exit certain markets altogether. In industries being disrupted by new entrants with distinct business models, incumbents often have an important advantage: entrenched regulatory and legal barriers. In the U.S.,

Licensing 8

Licensing Proposal Retail Long-term 8

Harvard Business Review

DECEMBER 23, 2016

What distinguished successful from unsuccessful alliances was more of a “productive” irritation — creative tension between differing ideas about how to develop alliance products – reflected in disagreements about the strategy and tactics of how best to develop a particular molecule.

Productivity 8

Productivity Products Survey Strategic Fit 8

Harvard Business Review

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. Older people need more medicine. Read More from the Government of Japan.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Content 8